Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751, 871) in Combination with Paclitaxel and Carboplatin

D.D. Karp, M.N. Pollak, R.B. Cohen, P.D. Eisenberg, P. Haluska, D. Yin, A. Lipton, L. Demers, K. Leitzel, M.L. Hixon, Leonardus Wendelinus Mathias Marie Terstappen, L. Garland, L.G. Paz-Ares, F. Cardenal, A. Gualberto

Research output: Contribution to journalArticleAcademicpeer-review

57 Citations (Scopus)
Original languageUndefined
Pages (from-to)1397-1403
JournalJournal of thoracic oncology
Issue number11
Publication statusPublished - 2009


  • METIS-259828

Cite this